A Phase II Trial of RAD001 (Everolimus) for 2nd Line Treatment After Failure of Fluoropyrimidine Plus Platinum Chemotherapy in Patients With Metastatic or Recurrent Gastric Cancer With pS6 Ser 240/4 Expression.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Everolimus (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 12 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.